CSIMarket Company Name, Ticker, Industry, else..
 
Bellerophon Therapeutics inc  (NASDAQ: BLPH)
Other Ticker:  
 
 

BLPH's Market share relative to its competitors, as of Q3 2023

As of Q3 2023 (Revenue in Millions of $)

Date modified: 2025-03-09T03:13:05+00:00



COMPANY NAME REVENUES
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months
Q3 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE
A Quarter Before
Q2 2023
Bellerophon Therapeutics inc 0.00 0.00% 0.00 % 0.00 %
Arena Pharmaceuticals Inc 3.41 0.01% 0.00% 0.00%
Pulmatrix Inc 10.01 0.03% 0.00% 0.02%
Vericel Corporation 237.22 0.79% 0.92% 0.74%
Galecto Inc 0.00 0.00% 0.00% 0.00%
Zymeworks Inc 76.30 0.26% 0.38% 0.21%
Galapagos Nv 268.49 0.90% 0.90% 0.00%
Vertex Pharmaceuticals Inc 11,020.10 36.87% 35.38% 35.64%
Regeneron Pharmaceuticals Inc 14,202.00 47.51% 46.04% 47.84%
Sarepta Therapeutics Inc 1,901.98 6.36% 8.00% 6.01%
Milestone Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Deciphera Pharmaceuticals Inc 174.91 0.59% 0.55% 0.62%
Intercept Pharmaceuticals inc 288.25 0.96% 1.08% 1.08%
Ironwood Pharmaceuticals inc 407.14 1.36% 1.32% 1.25%
Supernus Pharmaceuticals inc 661.82 2.21% 2.12% 2.26%
Nurix Therapeutics Inc 54.55 0.18% 0.16% 0.16%
Madrigal Pharmaceuticals Inc 0.00 0.00% 1.26% 0.80%
89bio Inc 0.00 0.00% 0.00% 0.00%
Relmada Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 1.46 0.00% 0.00% 0.00%
Oramed Pharmaceuticals Inc 2.70 0.01% 0.00% 0.00%
Reata Pharmaceuticals Inc 3.15 0.01% 0.28% 0.00%
Mira Pharmaceuticals Inc 0.00 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Gelesis Holdings Inc 12.14 0.04% 0.01% 0.02%
Tyme Technologies Inc. 0.00 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Galmed Pharmaceuticals Ltd 2.04 0.01% 0.00% 0.00%
Affimed N v 9.27 0.03% 0.03% 0.00%
Salarius Pharmaceuticals inc 4.70 0.02% 0.00% 0.00%
Paxmedica Inc 0.00 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 9.78 0.03% 0.01% 0.02%
Nextcure Inc 0.00 0.00% 0.00% 0.00%
Ibio inc 2.11 0.01% 0.00% 0.00%
Aadi Bioscience Inc 25.07 0.08% 0.09% 0.08%
Aeterna Zentaris Inc 4.50 0.02% 0.02% 0.00%
I mab 3.89 0.01% 0.01% 0.00%
Kineta Inc 0.00 0.00% 0.00% 0.00%
Diamedica Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Lumos Pharma Inc 2.21 0.01% 0.01% 0.01%
Alimera Sciences Inc 98.09 0.33% 0.32% 0.29%
Landos Biopharma Inc 0.00 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 2.16 0.01% 0.01% 0.01%
Y mabs Therapeutics inc 87.68 0.29% 0.32% 0.24%
Cingulate Inc 0.00 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00 0.00% 0.00% 0.00%
Pliant Therapeutics Inc 9.85 0.03% 0.00% 0.00%
Xoma Royalty Corporation 21.61 0.07% 0.09% 0.14%
Rhythm Pharmaceuticals inc 130.13 0.44% 0.51% 0.43%
Nuvalent Inc 4.23 0.01% 0.00% 0.00%
Adc Therapeutics Sa 123.49 0.41% 0.22% 0.22%
Adagene Inc 18.11 0.06% 0.06% 0.00%
Adlai Nortye Ltd 5.00 0.02% 0.02% 0.00%
Talphera Inc 1.52 0.01% 0.00% 0.00%
SUBTOTAL 29,891.05 100% 8,230.72 100%



BLPH's Market share relative to its competitors, as of Q3 2023 within the Major Pharmaceutical Preparations Industry
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Bellerophon Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Arena Pharmaceuticals Inc 0.01% 0.01% 0.00% 0.00%
Pulmatrix Inc 0.03% 0.04% 0.00% 0.02%
Galecto Inc 0.00% 0.00% 0.00% 0.00%
Zymeworks Inc 0.26% 0.21% 0.38% 0.21%
Galapagos Nv 0.91% 1.95% 0.91% 1.95%
Vertex Pharmaceuticals Inc 37.16% 36.61% 35.71% 35.91%
Regeneron Pharmaceuticals Inc 47.89% 47.71% 46.46% 48.20%
Sarepta Therapeutics Inc 6.41% 5.65% 8.07% 6.05%
Milestone Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Deciphera Pharmaceuticals Inc 0.59% 0.56% 0.55% 0.63%
Intercept Pharmaceuticals inc 0.97% 0.95% 1.09% 1.08%
Ironwood Pharmaceuticals inc 1.37% 1.39% 1.33% 1.26%
Supernus Pharmaceuticals inc 2.23% 2.21% 2.14% 2.28%
Nurix Therapeutics Inc 0.18% 0.19% 0.16% 0.16%
Madrigal Pharmaceuticals Inc 0.00% 0.00% 1.27% 0.81%
89bio Inc 0.00% 0.00% 0.00% 0.00%
Relmada Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00% 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Oramed Pharmaceuticals Inc 0.01% 0.01% 0.00% 0.00%
Reata Pharmaceuticals Inc 0.01% 0.01% 0.28% 0.00%
Mira Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Gelesis Holdings Inc 0.04% 0.07% 0.01% 0.02%
Tyme Technologies Inc. 0.00% 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Galmed Pharmaceuticals Ltd 0.01% 0.01% 0.00% 0.00%
Affimed N v 0.03% 0.16% 0.03% 0.16%
Salarius Pharmaceuticals inc 0.02% 0.02% 0.00% 0.00%
Paxmedica Inc 0.00% 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00% 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 0.03% 0.04% 0.01% 0.02%
Nextcure Inc 0.00% 0.00% 0.00% 0.00%
Ibio inc 0.01% 0.01% 0.00% 0.00%
Aadi Bioscience Inc 0.08% 0.08% 0.09% 0.08%
Aeterna Zentaris Inc 0.02% 0.02% 0.02% 0.02%
I mab 0.01% -0.11% 0.01% -0.11%
Kineta Inc 0.00% 0.00% 0.00% 0.00%
Diamedica Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Lumos Pharma Inc 0.01% 0.01% 0.01% 0.01%
Alimera Sciences Inc 0.33% 0.31% 0.32% 0.29%
Landos Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 0.01% 0.01% 0.01% 0.01%
Y mabs Therapeutics inc 0.30% 0.28% 0.32% 0.24%
Cingulate Inc 0.00% 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Pliant Therapeutics Inc 0.03% 0.02% 0.00% 0.00%
Xoma Royalty Corporation 0.07% 0.05% 0.09% 0.14%
Rhythm Pharmaceuticals inc 0.44% 0.38% 0.51% 0.43%
Nuvalent Inc 0.01% 0.01% 0.00% 0.00%
Adc Therapeutics Sa 0.42% 1.09% 0.23% 0.23%
Adagene Inc 0.06% 0.03% 0.06% 0.03%
Adlai Nortye Ltd 0.02% 0.00% 0.02% 0.00%
Talphera Inc 0.01% 0.01% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



BLPH's Market share relative to its competitors, as of Q3 2023 within the Healthcare Sector
As of Q3 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q3 2023		 MARKET SHARE
12 Months Ending
Q2 2023		 MARKET SHARE
MRQ
Q3 2023		 MARKET SHARE

Q2 2023
Bellerophon Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Arena Pharmaceuticals Inc 0.01% 0.01% 0.00% 0.00%
Pulmatrix Inc 0.03% 0.04% 0.00% 0.02%
Vericel Corporation 0.79% 0.78% 0.92% 0.74%
Galecto Inc 0.00% 0.00% 0.00% 0.00%
Zymeworks Inc 0.26% 0.21% 0.38% 0.21%
Galapagos Nv 0.90% 1.93% 0.90% 1.93%
Vertex Pharmaceuticals Inc 36.87% 36.32% 35.38% 35.64%
Regeneron Pharmaceuticals Inc 47.51% 47.34% 46.04% 47.84%
Sarepta Therapeutics Inc 6.36% 5.61% 8.00% 6.01%
Milestone Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Deciphera Pharmaceuticals Inc 0.59% 0.56% 0.55% 0.62%
Intercept Pharmaceuticals inc 0.96% 0.95% 1.08% 1.08%
Ironwood Pharmaceuticals inc 1.36% 1.38% 1.32% 1.25%
Supernus Pharmaceuticals inc 2.21% 2.19% 2.12% 2.26%
Nurix Therapeutics Inc 0.18% 0.19% 0.16% 0.16%
Madrigal Pharmaceuticals Inc 0.00% 0.00% 1.26% 0.80%
89bio Inc 0.00% 0.00% 0.00% 0.00%
Relmada Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Iveric Bio Inc 0.00% 0.00% 0.00% 0.00%
Kinnate Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Terns Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Actinium Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Oramed Pharmaceuticals Inc 0.01% 0.01% 0.00% 0.00%
Reata Pharmaceuticals Inc 0.01% 0.01% 0.28% 0.00%
Mira Pharmaceuticals Inc 0.00% 0.00% 0.00% 0.00%
Inhibitor Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Gelesis Holdings Inc 0.04% 0.07% 0.01% 0.02%
Tyme Technologies Inc. 0.00% 0.00% 0.00% 0.00%
Effector Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Galmed Pharmaceuticals Ltd 0.01% 0.01% 0.00% 0.00%
Affimed N v 0.03% 0.16% 0.03% 0.16%
Salarius Pharmaceuticals inc 0.02% 0.02% 0.00% 0.00%
Paxmedica Inc 0.00% 0.00% 0.00% 0.00%
Phio Pharmaceuticals Corp 0.00% 0.00% 0.00% 0.00%
Bolt Biotherapeutics Inc 0.03% 0.04% 0.01% 0.02%
Nextcure Inc 0.00% 0.00% 0.00% 0.00%
Ibio inc 0.01% 0.01% 0.00% 0.00%
Aadi Bioscience Inc 0.08% 0.08% 0.09% 0.08%
Aeterna Zentaris Inc 0.02% 0.02% 0.02% 0.02%
I mab 0.01% -0.11% 0.01% -0.11%
Kineta Inc 0.00% 0.00% 0.00% 0.00%
Diamedica Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Lumos Pharma Inc 0.01% 0.01% 0.01% 0.01%
Alimera Sciences Inc 0.33% 0.30% 0.32% 0.29%
Landos Biopharma Inc 0.00% 0.00% 0.00% 0.00%
Tempest Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Oncternal Therapeutics Inc 0.01% 0.01% 0.01% 0.01%
Y mabs Therapeutics inc 0.29% 0.28% 0.32% 0.24%
Cingulate Inc 0.00% 0.00% 0.00% 0.00%
Enliven Therapeutics Inc 0.00% 0.00% 0.00% 0.00%
Pliant Therapeutics Inc 0.03% 0.02% 0.00% 0.00%
Xoma Royalty Corporation 0.07% 0.05% 0.09% 0.14%
Rhythm Pharmaceuticals inc 0.44% 0.38% 0.51% 0.43%
Nuvalent Inc 0.01% 0.01% 0.00% 0.00%
Adc Therapeutics Sa 0.41% 1.08% 0.22% 0.22%
Adagene Inc 0.06% 0.03% 0.06% 0.03%
Adlai Nortye Ltd 0.02% 0.00% 0.02% 0.00%
Talphera Inc 0.01% 0.01% 0.00% 0.00%
SUBTOTAL 100% 100% 100% 100%



Note: Market share is calculated based on total revenue. To get a more accurate picture of Bellerophon Therapeutics inc's market divisions, geographic dispersion, segments, products, and services, visit Bellerophon Therapeutics inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com